Home News COVID-19: FG directs all civil servants to resume, get vaccinated

COVID-19: FG directs all civil servants to resume, get vaccinated

0
COVID-19: FG directs all civil servants to resume, get vaccinated

The Federal government has directed civil servants from Grade Level 12 and below to resume work effective Wednesday, December 1, 2021.

The federal civil service workers from Grade Level 12 and below had been working from home following a spike in COVID-19 cases across the country.

In the now-viral circular seen by The Nation, the directive, signed by the Head of Service of the Federation, Folasade Yemi-Esan, noted that beginning December 1, all Federal Government workers are requested “to show proof of COVID-19 vaccination or present a negative COVID-19 PCR test result done within 72 hours.”

“It will be recalled that as part of the measures to curtail the spread of COVID-19 pandemic, Officers on GL 12 and below were directed to work from home. Following the advice of the PSC on COVID-19, this category of officers are expected to resume duties on Wednesday, 1st December 2021,” the circular reads in part

Recall that the chairman of the Presidential Steering Committee (PSC) on COVID-19, Boss Mustapha, had earlier announced that beginning December 1, 2021 all Federal Government employees will be required to show proof of COVID-19 vaccination or present a negative PCR result to gain access to their offices.

Meanwhile, the World Health Organization (WHO) has announced a new COVID-19 variant called the B.1.1.529 named Omicron, which was first reported in South Africa.

Noting that the new variant has been associated with recent increased infections in South Africa, the global body added that the variant is also associated with an increased risk of reinfection compared to other Variants of Concern (VoC). It therefore urged countries to ramp up efforts in surveillance, diagnosis, sequencing, and public health and social measures.

“This variant has a large number of mutations, some of which are concerning. Preliminary evidence suggests an increased risk of reinfection with this variant, as compared to other VoCs. The number of cases of this variant appears to be increasing in almost all provinces in South Africa. Current SARS-CoV-2 PCR diagnostics continue to detect this variant.

“Several labs have indicated that for one widely used PCR test, one of the three target genes is not detected (called S gene dropout or S gene target failure) and this test can therefore be used as marker for this variant, pending sequencing confirmation. Using this approach, this variant has been detected at faster rates than previous surges in infection, suggesting that this variant may have a growth advantage,” it stated.

Furthermore, WHO has also urged the Federal Government to continue to sustain and scale up COVID-19 interventions, even as many countries in the regions of the Americas, Europe, and South-East Asia, continue to experience a fourth wave of the pandemic, with increasing cases.

It noted that while Europe continues to drive the upsurge of cases globally, Africa and specifically Nigeria, continues to report low cases of the disease.

The WHO Health Emergency Information and Risk Assessment Lead, Dr Geoffrey Namara, made this known in Nasarawa, during the 5th Annual Conference of the Association of Nigeria Health Journalists (ANHEJ), with theme: “Improving confidence in COVID-19 vaccine in Nigeria beyond 2022, the role of the media.”

He noted that COVID-19 vaccination coverage is still low compared to the government’s target to vaccinate 70 per cent of the population by next year. He therefore urged the media to use their platforms to encourage Nigerians to get vaccinated.

“Europe is driving the upsurge of COVID-19 cases globally. As countries continue to experience a surge in cases, Nigeria is experiencing low numbers. Nigeria should therefore sustain whatever it is doing because the cases are reducing.

“In terms of COVID-19 VACCINATION coverage, 6.11 million Nigerians have received the first dose. 3.41 million eligible Nigerians have received a second dose. Of the vaccines received, 2.04 million were AstraZeneca, 1.15 million were Moderna. We need to put in efforts to scale up COVID-19 vaccination,” he said.